Novo Nordisk A/S (NVO) Short Interest Ratio & Short Volume $59.10 -0.55 (-0.92%) Closing price 03:59 PM EasternExtended Trading$59.08 -0.02 (-0.04%) As of 05:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Novo Nordisk A/S Short Interest DataNovo Nordisk A/S (NVO) has a short interest of 28.74 million shares. This marks a 11.48% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.7, indicating that it would take 1.7 days of the average trading volume of 12.18 million shares to cover all short positions.Current Short Interest28,740,000 sharesPrevious Short Interest25,780,000 sharesChange Vs. Previous Month+11.48%Dollar Volume Sold Short$1.60 billionShort Interest Ratio1.7 Days to CoverLast Record DateSeptember 15, 2025Outstanding Shares4,465,000,000 sharesPercentage of Shares Shorted0.64%Today's Trading Volume9,646,031 sharesAverage Trading Volume12,178,689 sharesToday's Volume Vs. Average79% Short Selling Novo Nordisk A/S? Sign up to receive the latest short interest report for Novo Nordisk A/S and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNVO Short Interest Over TimeNVO Days to Cover Over TimeNVO Percentage of Float Shorted Over Time Novo Nordisk A/S Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/15/202528,740,000 shares $1.60 billion +11.5%N/A1.7 $55.62 8/31/202525,780,000 shares $1.46 billion +22.7%0.6%1.6 $56.51 8/15/202521,020,000 shares $1.10 billion +1.3%N/A1.4 $52.43 7/31/202520,760,000 shares $976.11 million -12.0%0.5%1.5 $47.02 7/15/202523,580,000 shares $1.59 billion -8.3%N/A2.5 $67.32 6/30/202525,700,000 shares $1.77 billion -3.4%0.6%2.5 $69.06 6/15/202526,610,000 shares $2.13 billion -21.0%0.6%2.6 $79.90 5/31/202533,670,000 shares $2.40 billion +22.1%0.8%3.4 $71.40 5/15/202527,580,000 shares $1.82 billion +9.8%0.6%2.9 $66.07 4/30/202525,120,000 shares $1.67 billion +31.7%N/A2.7 $66.53 Get the Latest News and Ratings for NVO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Novo Nordisk A/S and its competitors with MarketBeat's FREE daily newsletter. 4/15/202519,070,000 shares $1.23 billion +30.1%0.4%2.1 $64.46 3/31/202514,660,000 shares $1.02 billion +16.0%0.3%1.7 $69.58 3/15/202512,640,000 shares $976.09 million -6.4%0.3%1.4 $77.22 2/28/202513,510,000 shares $1.23 billion -0.2%0.3%1.5 $90.68 2/15/202513,530,000 shares $1.05 billion -0.3%0.3%1.6 $77.94 1/31/202513,570,000 shares $1.14 billion +64.1%N/A1.7 $84.36 1/15/20258,270,000 shares $686.33 million -0.4%N/A1.1 $82.99 12/31/20248,300,000 shares $713.97 million +76.6%N/A1.3 $86.02 12/15/20244,700,000 shares $502.67 million -17.3%N/A0.8 $106.95 11/30/20245,680,000 shares $606.62 million +15.2%N/A1.1 $106.80 11/15/20244,930,000 shares $501.58 million -18.5%N/A1 $101.74 10/31/20246,050,000 shares $677.36 million -4.9%N/A1.4 $111.96 10/15/20246,360,000 shares $749.40 million -9.5%N/A1.6 $117.83 9/30/20247,030,000 shares $836.92 million +21.2%N/A1.7 $119.05 9/15/20245,800,000 shares $794.60 million +13.1%N/A1.5 $137.00 8/31/20245,130,000 shares $713.89 million -2.7%N/A1.3 $139.16 8/15/20245,270,000 shares $724.99 million +30.1%N/A1.3 $137.57 7/31/20244,050,000 shares $537.15 million +28.6%N/A1 $132.63 7/15/20243,150,000 shares $445.38 million -30.3%N/A0.8 $141.39 6/30/20244,520,000 shares $645.18 million +3.7%N/A1.2 $142.74 6/15/20244,360,000 shares $621.30 million -2.7%N/A1.2 $142.50 5/31/20244,480,000 shares $606.14 million +20.8%N/A1.1 $135.30 5/15/20243,710,000 shares $499.51 million +1.9%N/A0.8 $134.64 4/30/20243,640,000 shares $466.94 million +12.4%N/A0.8 $128.28 4/15/20243,240,000 shares $401.27 million +14.5%N/A0.6 $123.85 3/31/20242,830,000 shares $363.37 million -31.1%N/A0.6 $128.40 3/15/20244,110,000 shares $543.96 million -15.8%N/A0.8 $132.35 2/29/20244,880,000 shares $584.33 million +4.5%N/A1 $119.74 2/15/20244,670,000 shares $568.43 million -37.9%N/A1 $121.72 1/31/20247,520,000 shares $862.47 million +37.7%N/A1.7 $114.69 1/15/20245,460,000 shares $585.09 million -5.0%N/A1.3 $107.16 12/31/20235,750,000 shares $594.84 million -11.1%N/A1.3 $103.45 12/15/20236,470,000 shares $628.04 million +15.5%N/A1.4 $97.07 11/30/20235,600,000 shares $570.33 million -6.2%N/A1.2 $101.85 11/15/20235,970,000 shares $575.63 million +34.8%N/A1.3 $96.42 10/31/20234,430,000 shares $427.81 million -26.3%N/A1 $96.57 10/15/20236,010,000 shares $613.86 million +1.7%N/A1.3 $102.14 9/30/20235,910,000 shares $537.46 million +5.4%N/A1.5 $90.94 9/15/20235,610,000 shares $267.03 million +187.7%0.3%1.6 $47.60 8/31/20231,950,000 shares $362.15 million -4.9%0.1%1.2 $185.72 8/15/20232,050,000 shares $379.50 million +106.0%0.1%1.4 $185.12 7/31/2023995,300 shares $160.34 million -21.0%0.1%0.7 $161.10 7/15/20231,260,000 shares $201.78 million -44.3%0.1%1 $160.14 6/30/20232,260,000 shares $365.74 million +9.2%0.1%1.6 $161.83 6/15/20232,070,000 shares $336.44 million +16.3%0.1%1.5 $162.53 5/31/20231,780,000 shares $285.69 million +14.1%0.1%1.3 $160.50 5/15/20231,560,000 shares $264.31 million +6.1%0.1%1.1 $169.43 4/30/20231,470,000 shares $245.62 million -14.5%0.1%1.1 $167.09 4/15/20231,720,000 shares $289.99 million -26.2%0.1%1.2 $168.60 3/31/20232,330,000 shares $370.80 million +66.4%0.1%1.7 $159.14 3/15/20231,400,000 shares $197.37 million +28.4%0.1%1 $140.98 2/28/20231,090,000 shares $153.68 million -3.5%0.1%0.8 $140.99 2/15/20231,130,000 shares $159.28 million -33.9%0.1%0.8 $140.96 1/31/20231,710,000 shares $237.31 million +3.6%0.1%1.2 $138.78 1/15/20231,650,000 shares $224.93 million -10.3%0.1%1.2 $136.32 12/30/20221,840,000 shares $249.03 million +34.3%0.1%1.4 $135.34 12/15/20221,370,000 shares $183.14 million -34.1%0.1%1 $133.68 11/30/20222,080,000 shares $259.17 million -20.6%0.1%1.6 $124.60 11/15/20222,620,000 shares $297.74 million -1.1%0.2%1.8 $113.64 10/31/20222,650,000 shares $288.43 million -17.7%0.2%1.7 $108.84 10/15/20223,220,000 shares $334.24 million +0.9%0.2%2 $103.80 9/30/20223,190,000 shares $317.82 million +2.2%0.2%1.9 $99.63 9/15/20223,120,000 shares $322.02 million -9.0%0.2%1.9 $103.21 8/31/20223,430,000 shares $363.92 million +48.5%0.2%2.1 $106.10 8/15/20222,310,000 shares $245.71 million +76.3%0.1%1.5 $106.37 7/31/20221,310,000 shares $152.04 million +26.0%0.1%0.9 $116.06 7/15/20221,040,000 shares $118.80 million -46.4%N/A0.7 $114.23 6/30/20221,940,000 shares $216.17 million -22.7%N/A1.3 $111.43 6/15/20222,510,000 shares $266.89 million +46.8%N/A1.7 $106.33 5/31/20221,710,000 shares $188.78 million -29.1%0.1%1.2 $110.40 5/15/20222,410,000 shares $255.56 million +39.3%0.1%1.6 $106.04 4/30/20221,730,000 shares $197.22 million -47.1%0.1%1.2 $114.00 4/15/20223,270,000 shares $386.51 million +58.0%0.2%2.3 $118.20 3/31/20222,070,000 shares $229.87 million -21.3%0.1%1.4 $111.05 3/15/20222,630,000 shares $269.44 million +10.0%0.2%1.7 $102.45 2/28/20222,390,000 shares $246.05 million -4.8%0.1%1.5 $102.95 2/15/20222,510,000 shares $254.41 million -24.6%0.1%1.7 $101.36 1/31/20223,330,000 shares $332.57 million +0.3%0.2%2.4 $99.87 1/15/20223,320,000 shares $319.78 million +18.2%0.2%2.6 $96.32 12/31/20212,810,000 shares $314.72 million +42.6%0.2%2.5 $112.00 12/15/20211,970,000 shares $229.43 million +3.1%0.1%1.9 $116.46 11/30/20211,910,000 shares $204.05 million -26.0%0.1%2.2 $106.83 11/15/20212,580,000 shares $292.80 million +22.3%0.2%2.8 $113.49 10/29/20212,110,000 shares $232.37 million -17.3%0.1%2.2 $110.13 10/15/20212,550,000 shares $260.97 million +8.1%0.2%2.5 $102.34 9/30/20212,360,000 shares $226.58 million -10.3%0.1%2.3 $96.01 9/15/20212,630,000 shares $266.34 million -24.0%0.2%2.6 $101.27 8/31/20213,460,000 shares $345.90 million +19.7%0.2%3.5 $99.97 8/13/20212,890,000 shares $296.98 million -30.5%0.2%3 $102.76 7/30/20214,160,000 shares $385.22 million -11.1%0.2%4.2 $92.60 7/15/20214,680,000 shares $410.01 million -5.1%0.3%5.2 $87.61 6/30/20214,930,000 shares $412.99 million -1.6%0.3%5.6 $83.77 6/15/20215,010,000 shares $423.70 million +7.1%0.3%5.6 $84.57 5/28/20214,680,000 shares $369.25 million +15.0%0.3%5.3 $78.90 5/14/20214,070,000 shares $321.08 million -15.2%0.2%4.6 $78.89 4/30/20214,800,000 shares $356.35 million +11.9%0.3%5 $74.24 4/15/20214,290,000 shares $302.66 million +1.4%0.2%4.4 $70.55 3/31/20214,230,000 shares $287.30 million -0.9%0.2%4.3 $67.92 3/15/20214,270,000 shares $303.21 million -6.2%0.2%4 $71.01 2/26/20214,550,000 shares $329.15 million +4.6%0.3%4.2 $72.34 2/12/20214,350,000 shares $321.60 million -12.7%0.2%4 $73.93 1/29/20214,980,000 shares $351.59 million +1.4%0.3%4.6 $70.60 1/15/20214,910,000 shares $348.76 million +21.2%0.3%4.3 $71.03 12/31/20204,050,000 shares $284.31 million -1.0%0.2%3.6 $70.20 12/15/20204,090,000 shares $281.06 million -17.9%0.2%3.6 $68.72 11/30/20204,980,000 shares $336.35 million -12.2%0.3%4.5 $67.54 11/15/20205,670,000 shares $386.01 million +13.2%0.3%5.3 $68.08 10/30/20205,010,000 shares $332.31 million +21.6%0.3%4.8 $66.33 10/15/20204,120,000 shares $295.53 million -1.2%0.2%4.4 $71.73 NVO Short Interest - Frequently Asked Questions What is Novo Nordisk A/S's current short interest? Short interest is the volume of Novo Nordisk A/S shares that have been sold short but have not yet been covered or closed out. As of September 15th, investors have sold 28,740,000 shares of NVO short. Learn More on Novo Nordisk A/S's current short interest. What is a good short interest ratio for Novo Nordisk A/S? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NVO shares currently have a short interest ratio of 2.0. Learn More on Novo Nordisk A/S's short interest ratio. Which institutional investors are shorting Novo Nordisk A/S? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Novo Nordisk A/S: Hudson Bay Capital Management LP, Nomura Holdings Inc., LMR Partners LLP, Hudson Bay Capital Management LP, Group One Trading LLC, Balyasny Asset Management L.P., 683 Capital Management LLC, Jane Street Group LLC, Qube Research & Technologies Ltd, CMT Capital Markets Trading GmbH, Marshall Wace LLP, Walleye Capital LLC, Walleye Trading LLC, Lido Advisors LLC, Hsbc Holdings PLC, Capital Fund Management S.A., DLD Asset Management LP, Eisler Capital Management Ltd., JPMorgan Chase & Co., Citigroup Inc., Simplex Trading LLC, Twin Tree Management LP, and IMC Chicago LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Novo Nordisk A/S's short interest increasing or decreasing? Novo Nordisk A/S saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 28,740,000 shares, an increase of 11.5% from the previous total of 25,780,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Novo Nordisk A/S's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Novo Nordisk A/S: Novartis AG (0.22%), AstraZeneca PLC (0.25%), Sanofi (0.20%), GSK PLC Sponsored ADR (0.55%), Takeda Pharmaceutical Co. (0.30%), argenex SE (2.84%), BeOne Medicines Ltd. - Sponsored ADR (1.57%), Insmed, Inc. (5.01%), BioNTech SE Sponsored ADR (2.70%), Teva Pharmaceutical Industries Ltd. (4.81%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Corporation ($8.81 billion), Canadian Natural Resources Limited ($5.82 billion), Reddit Inc. ($5.19 billion), Coinbase Global, Inc. ($4.52 billion), Robinhood Markets, Inc. ($4.30 billion), Charter Communications, Inc. ($3.75 billion), CoreWeave Inc. ($3.66 billion), Seagate Technology Holdings PLC ($3.57 billion), Live Nation Entertainment, Inc. ($3.33 billion), and Rocket Lab Corporation ($3.26 billion). View all of the most shorted stocks. What does it mean to sell short Novo Nordisk A/S stock? Short selling NVO is an investing strategy that aims to generate trading profit from Novo Nordisk A/S as its price is falling. NVO shares are trading down $0.15 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Novo Nordisk A/S? A short squeeze for Novo Nordisk A/S occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NVO, which in turn drives the price of the stock up even further. How often is Novo Nordisk A/S's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NVO, twice per month. The most recent reporting period available is September, 15 2025. More Short Interest Resources from MarketBeat Related Companies Novartis Short Squeeze AstraZeneca Short Squeeze Sanofi Short Squeeze GSK Short Squeeze Takeda Pharmaceutical Short Squeeze argenex Short Squeeze BeOne Medicines Short Squeeze Insmed Short Squeeze BioNTech Short Squeeze Teva Pharmaceutical Industries Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:NVO) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novo Nordisk A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Novo Nordisk A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
